Amyloidosis

Known as: Amyloidosis NOS, AMYLOID, amyloid diseases 
A group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis… (More)
National Institutes of Health

Related topics

Related topics

48 relations
2 ML Digoxin 0.25 MG/ML InjectionAcetylcysteineAcetylcysteine 200 MG/ML Inhalant SolutionAmyloid
(More)

Narrower (14)

AMYLOIDOSIS, HEREDITARY, CARDIOPATHICAMYLOIDOSIS, SECONDARY GENERALIZEDAmyloid Neuropathies, FamilialAmyloidosis, Primary Cutaneous
(More)

Broader (2)

Inborn Errors of MetabolismMetabolic Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Elucidating the Role of TREM2 in Alzheimer’s Disease
Alzheimer's disease (AD) is the sixth leading cause of death in the United States and the most common cause of dementia in the… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept
Preclinical Alzheimer's disease (AD) is a relatively recent concept describing an entity characterized by the presence of a… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Safety and efficacy of RNAi therapy for transthyretin amyloidosis.
BACKGROUND Transthyretin amyloidosis is caused by the deposition of hepatocyte-derived transthyretin amyloid in peripheral nerves… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Natural history and outcome in systemic AA amyloidosis.
BACKGROUND Deposition of amyloid fibrils derived from circulating acute-phase reactant serum amyloid A protein (SAA) causes… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.
We have generated a novel transgenic mouse model on a C57BL/6J genetic background that coexpresses KM670/671NL mutated amyloid… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 3
Is this relevant?
Review
2005
Review
2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours…
We undertook this study to develop uniformly accepted criteria for the definition of organ involvement and response for patients… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Definition of Organ Involvement and Treatment Response in Immunoglobulin Light Chain Amyloidosis ( AL ) : A Consensus Opinion From the 10 th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz,* Ray Comenzo, Rodney H. Falk, Jean Paul Fermand, Bouke P. Hazenberg, Philip N. Hawkins, Giampaolo Merlini… (More)
  • table I
  • table III
  • table II
  • table IV
Is this relevant?
Review
2003
Review
2003
Molecular mechanisms of amyloidosis.
From the Amyloid Center, Biotechnology Research Laboratory, University Hospital IRCCS Policlinico San Matteo; and the Department… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.
Oxidative stress is a key feature in the Alzheimer's disease (AD) brain and manifests as lipid peroxidation (LPO). Isoprostanes… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease.
Age-related macular degeneration (AMD), a blinding disorder that compromises central vision, is characterized by the accumulation… (More)
Is this relevant?